Oncology Institute (TOIIW) Equity Ratio (2019 - 2026)

Oncology Institute (TOIIW) has reported Equity Ratio for 8 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.1, down 413.19% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.1 (down 413.19% YoY), and the FY2025 annual result was 0.1, down 559.45% from the prior year.
• Equity Ratio was 0.1 for Q1 2026 at Oncology Institute, down from 0.1 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.65 in Q2 2022 and troughed at 0.1 in Q1 2026.
• Average Equity Ratio over 5 years is 0.22, with a median of 0.2 recorded in 2024.
• Year-over-year, Equity Ratio jumped 213.23% in 2022 and sank 559.45% in 2025.
• Over 5 years, Equity Ratio stood at 0.47 in 2022, then slumped by 42.1% to 0.27 in 2023, then sank by 92.38% to 0.02 in 2024, then plunged by 559.45% to 0.1 in 2025, then retreated by 1.39% to 0.1 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.1 in Q1 2026, 0.1 in Q4 2025, and 0.08 in Q3 2025.